AUSTIN, Texas, Sept. 26, 2023 /PRNewswire/ -- Alafair Biosciences has been selected to exhibit VersaWrap, a class II medical device, at the Vizient Innovative Technology Exchange. Vizient, Inc, the ...
AUSTIN, Texas, Dec. 19, 2024 /PRNewswire/ -- Alafair Biosciences announced today that it has surpassed 22,000 patient implants of its flagship product, VersaWrap Hydrogel Sheet, marking a significant ...
AUSTIN, Texas, May 23, 2019 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that sales of its initial product, VersaWrap® Tendon Protector (VersaWrap), ...
VersaWrap is an FDA-cleared medical device implant (not tissue) comprising hyaluronic acid (HA) and alginate that provides a gelatinous encasement for peripheral nerves, tendons, and surrounding ...
AUSTIN, Texas, Nov. 21, 2023 /PRNewswire/ -- Alafair Biosciences, Inc., a commercial-stage medical device company, announced that surgeons have implanted over 12,000 units of its flagship product, ...
Alafair Biosciences, Inc., a privately held medical device company, announced that its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), has been awarded a national group purchasing agreement ...
AUSTIN, Texas, June 25, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a leading innovator in medical device technology, is pleased to announce the first patient enrolled at UC Davis Foot and Ankle ...
AUSTIN, Texas, Sept. 16, 2024 /PRNewswire/ -- Alafair Biosciences is proud to announce that it has been selected to exhibit its flagship product, VersaWrap Hydrogel Sheet (VersaWrap), at the Vizient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results